Building Companies
The OBIO® Capital Access Advisory Program (CAAP®) operates downstream from existing entrepreneurship programs and focuses on accelerating technology commercialization, working towards Series A financing and strategic partnerships. OBIO’s CAAP® creates high value deal flow for both companies and investors, and opportunity to participate at the OBIO® Investment Summit and other international investment conferences.
What is OBIO’s CAAP®?
A competitive, 9-12 month structured program for health science companies starting to raise a post-seed financing round over the next 12-18 months.
CAAP® covers three fundamental business themes:
Business strategic planning & increasing the ROI for investors
Advanced fundraising strategies
Closing an investment round and business development contract
Benefits for CAAP® companies:
Strategic Connections: Receive warm introductions and strategic guidance to venture investors, healthcare executives and business experts customized to your business strategy
Lead Generation: Leverage support from the OBIO® team to reach out to VCs and strategic partners at international conferences to generate new leads
Valuable Network Access: Get connected with the CAAP® and EAHN® alumni network of founders, as well as executive teams from OBIO® companies that have successfully closed financing
Continuous Support: Enjoy ongoing support throughout your company’s journey, become a CAAP® alumnus
Eligibility requirements:
Be a private, high-potential bioscience company based in Ontario
Focus on developing human health science products including but not limited to: therapeutics, medical devices, diagnostics or digital health technologies
Starting to raise a post-seed financing round in the next 12-18 months
Have enough resources and funding runway to reach key value inflection points
Chief Executive Officer and/or other members of the senior management team of each company admitted into the program must be actively engaged in the program. This includes participation in CAAP® specific workshops and other events throughout the CAAP® term
CAAP® culminates with a presentation at the OBIO® Investment Summit (OIS):
• Present to and meet with global health sciences investors & strategics
• > $3B raised by Summit companies since 2018
• 275+ companies have presented at the Summit
*We are not currently accepting applications*
Have a question? Contact us:
Parnian Tajbakhsh
Senior Manager, Capital Access
parniantajbakhsh@obio.ca
CAAP® Companies 2024-2025
CAAP® Companies 2023
CAAP® Companies 2022
CAAP® Companies 2021
CAAP® Companies 2020
CAAP® Companies 2019
FUNDED BY THE GOVERNMENT OF CANADA.